newsfilter
← Latest News
Business Wire·

The Medicines Company Reaches Enrollment Target for ORION-9 Ahead of Schedule

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ: MDCO) today announced that the target of 400 patients randomized in the ORION-9 trial has been exceeded in 10 weeks – considerably ahead of its anticipated recruitment goal of 24 weeks.